QurAlis
Marisa Kamelgarn, Ph.D., is a Senior Scientist at QurAlis, where leadership in a splice switching ASO program and ASO platform is asserted, alongside the establishment of Go/No-Go decision processes for new pipeline projects. Prior experience includes roles at Biogen as Scientist I and II, and Postdoctoral Scientist, contributing to critical assay development for drug target evaluation under distinguished mentorships. Marisa's academic background consists of a Ph.D. in Toxicology from the University of Kentucky, where significant advancements in molecular and biochemical techniques were made, and a Bachelor of Science in Biology from Morehead State University, where research focused on assessing local water contamination levels.
QurAlis
1 followers
QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. They are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus their programs on tackling specific disease-causing mechanisms.